Loading…

Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats

1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; 2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo; and 3 Department of Integrative Physiology, University of Fukui, Fukui,...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology: endocrinology and metabolism 2005-11, Vol.289 (5), p.E753-E761
Main Authors: Hashimoto, Hirofumi, Hyodo, Susumu, Kawasaki, Makoto, Mera, Takashi, Chen, Lei, Soya, Atsushi, Saito, Takeshi, Fujihara, Hiroaki, Higuchi, Takashi, Takei, Yoshio, Ueta, Yoichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83
cites cdi_FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83
container_end_page E761
container_issue 5
container_start_page E753
container_title American journal of physiology: endocrinology and metabolism
container_volume 289
creator Hashimoto, Hirofumi
Hyodo, Susumu
Kawasaki, Makoto
Mera, Takashi
Chen, Lei
Soya, Atsushi
Saito, Takeshi
Fujihara, Hiroaki
Higuchi, Takashi
Takei, Yoshio
Ueta, Yoichi
description 1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; 2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo; and 3 Department of Integrative Physiology, University of Fukui, Fukui, Japan Submitted 4 February 2005 ; accepted in final form 9 June 2005 We examined the effects of intracerebroventricular (ICV) administration of adrenomedullin 2 (AM2) on plasma oxytocin (OXT) and arginine vasopressin (AVP) levels in conscious rats. Plasma OXT levels were markedly increased 5 min after ICV administration of AM2 (1 nmol/rat) compared with vehicle and remained elevated in samples taken at 10, 15, 30, and 60 min. By contrast, plasma AVP levels were not significantly elevated in samples taken between 5 and 180 min after ICV administration of AM2 except at the 30-min time point. Fos-like immunoreactivity (Fos-LI) was observed in various brain areas, including the paraventricular (PVN) and the supraoptic nuclei (SON) after ICV administration of AM2 (2 nmol/rat) in conscious rats (measured at 90 min post-AM2 infusion). Dual immunostaining for OXT/Fos and AVP/Fos showed that OXT-LI neurons predominantly exhibited nuclear Fos-LI compared with AVP-LI neurons in the PVN and the SON. In situ hybridization histochemistry showed that ICV administration of AM2 (0.2, 1, and 2 nmol/rat) caused marked induction of the expression of the c- fos gene in the PVN and the SON. This induction was significantly reduced by pretreatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37) (3 nmol/rat) and the AM receptor antagonist AM-(22–52) (27 nmol/rat). These results suggest that centrally administered AM2 mainly activates OXT-secreting neurons in the PVN and the SON, at least in part through the CGRP and/or AM receptors with marked elevation of plasma OXT levels in conscious rats. c- fos ; fos; paraventricular nucleus; supraoptic nucleus; vasopressin Address for reprint requests and other correspondence: Y. Ueta, Dept. of Physiology, School of Medicine, Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan (e-mail: yoichi{at}med.uoeh-u.ac.jp )
doi_str_mv 10.1152/ajpendo.00042.2005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17392200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17392200</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83</originalsourceid><addsrcrecordid>eNqFkUGP1CAYhonRuOPqH_BgOHmyI9DSlqOZ7KrJJl7WM6HlY4YNhQpUtz9h_7WMM-uejCfg433efHlfhN5SsqWUs4_qbgavw5YQ0rAtI4Q_Q5vywSrKOX-ONoSKuqJ9Iy7Qq5Tuiq7jDXuJLigXvCW83qCHHfgclXMrVnqy3qYMEXR5RPBhAr04Zz1mWI3Z_lQZEj6sc8gH5dRkRxzu1xxG66sEY4Rs_R57WGLw6QMe1ZKOA3BwJDWenUqT-svgMgeHyyWqnF6jF0a5BG_O5yX6fn11u_tS3Xz7_HX36aYaG0JzBXpoREc16IYZ0rdG9IbpQUEz9JT33TgooYVRZKwHgLZujNC14V1JhxCj-_oSvT_5zjH8WCBlOdk0gnPKQ1iSbPu2FaLp_iukXS1YSb0I2Uk4xpBSBCPnaCcVV0mJPDYlz03JP03JY1MFend2X4YS8xNyrqYIxElwsPvDLxtBzoc12eDCfpXXpZZbuM-PzqwXksurjtdy1qaw1b_Zx2WemPo3wBq6zw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17392200</pqid></control><display><type>article</type><title>Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats</title><source>American Physiological Society Free</source><creator>Hashimoto, Hirofumi ; Hyodo, Susumu ; Kawasaki, Makoto ; Mera, Takashi ; Chen, Lei ; Soya, Atsushi ; Saito, Takeshi ; Fujihara, Hiroaki ; Higuchi, Takashi ; Takei, Yoshio ; Ueta, Yoichi</creator><creatorcontrib>Hashimoto, Hirofumi ; Hyodo, Susumu ; Kawasaki, Makoto ; Mera, Takashi ; Chen, Lei ; Soya, Atsushi ; Saito, Takeshi ; Fujihara, Hiroaki ; Higuchi, Takashi ; Takei, Yoshio ; Ueta, Yoichi</creatorcontrib><description>1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; 2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo; and 3 Department of Integrative Physiology, University of Fukui, Fukui, Japan Submitted 4 February 2005 ; accepted in final form 9 June 2005 We examined the effects of intracerebroventricular (ICV) administration of adrenomedullin 2 (AM2) on plasma oxytocin (OXT) and arginine vasopressin (AVP) levels in conscious rats. Plasma OXT levels were markedly increased 5 min after ICV administration of AM2 (1 nmol/rat) compared with vehicle and remained elevated in samples taken at 10, 15, 30, and 60 min. By contrast, plasma AVP levels were not significantly elevated in samples taken between 5 and 180 min after ICV administration of AM2 except at the 30-min time point. Fos-like immunoreactivity (Fos-LI) was observed in various brain areas, including the paraventricular (PVN) and the supraoptic nuclei (SON) after ICV administration of AM2 (2 nmol/rat) in conscious rats (measured at 90 min post-AM2 infusion). Dual immunostaining for OXT/Fos and AVP/Fos showed that OXT-LI neurons predominantly exhibited nuclear Fos-LI compared with AVP-LI neurons in the PVN and the SON. In situ hybridization histochemistry showed that ICV administration of AM2 (0.2, 1, and 2 nmol/rat) caused marked induction of the expression of the c- fos gene in the PVN and the SON. This induction was significantly reduced by pretreatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37) (3 nmol/rat) and the AM receptor antagonist AM-(22–52) (27 nmol/rat). These results suggest that centrally administered AM2 mainly activates OXT-secreting neurons in the PVN and the SON, at least in part through the CGRP and/or AM receptors with marked elevation of plasma OXT levels in conscious rats. c- fos ; fos; paraventricular nucleus; supraoptic nucleus; vasopressin Address for reprint requests and other correspondence: Y. Ueta, Dept. of Physiology, School of Medicine, Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan (e-mail: yoichi{at}med.uoeh-u.ac.jp )</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00042.2005</identifier><identifier>PMID: 15956053</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenomedullin ; Animals ; Arginine Vasopressin - antagonists &amp; inhibitors ; Arginine Vasopressin - blood ; Arginine Vasopressin - metabolism ; Calcitonin Gene-Related Peptide - pharmacology ; Calcitonin Gene-Related Peptide Receptor Antagonists ; Immunohistochemistry ; In Situ Hybridization ; Injections, Intraventricular ; Male ; Neurons - drug effects ; Neurons - metabolism ; Neuropeptides - pharmacology ; Oxytocin - antagonists &amp; inhibitors ; Oxytocin - blood ; Oxytocin - metabolism ; Paraventricular Hypothalamic Nucleus - cytology ; Paraventricular Hypothalamic Nucleus - drug effects ; Paraventricular Hypothalamic Nucleus - metabolism ; Peptide Fragments - pharmacology ; Proto-Oncogene Proteins c-fos - biosynthesis ; Proto-Oncogene Proteins c-fos - genetics ; Rats ; Rats, Wistar ; Supraoptic Nucleus - cytology ; Supraoptic Nucleus - drug effects ; Supraoptic Nucleus - metabolism</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2005-11, Vol.289 (5), p.E753-E761</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83</citedby><cites>FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15956053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashimoto, Hirofumi</creatorcontrib><creatorcontrib>Hyodo, Susumu</creatorcontrib><creatorcontrib>Kawasaki, Makoto</creatorcontrib><creatorcontrib>Mera, Takashi</creatorcontrib><creatorcontrib>Chen, Lei</creatorcontrib><creatorcontrib>Soya, Atsushi</creatorcontrib><creatorcontrib>Saito, Takeshi</creatorcontrib><creatorcontrib>Fujihara, Hiroaki</creatorcontrib><creatorcontrib>Higuchi, Takashi</creatorcontrib><creatorcontrib>Takei, Yoshio</creatorcontrib><creatorcontrib>Ueta, Yoichi</creatorcontrib><title>Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; 2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo; and 3 Department of Integrative Physiology, University of Fukui, Fukui, Japan Submitted 4 February 2005 ; accepted in final form 9 June 2005 We examined the effects of intracerebroventricular (ICV) administration of adrenomedullin 2 (AM2) on plasma oxytocin (OXT) and arginine vasopressin (AVP) levels in conscious rats. Plasma OXT levels were markedly increased 5 min after ICV administration of AM2 (1 nmol/rat) compared with vehicle and remained elevated in samples taken at 10, 15, 30, and 60 min. By contrast, plasma AVP levels were not significantly elevated in samples taken between 5 and 180 min after ICV administration of AM2 except at the 30-min time point. Fos-like immunoreactivity (Fos-LI) was observed in various brain areas, including the paraventricular (PVN) and the supraoptic nuclei (SON) after ICV administration of AM2 (2 nmol/rat) in conscious rats (measured at 90 min post-AM2 infusion). Dual immunostaining for OXT/Fos and AVP/Fos showed that OXT-LI neurons predominantly exhibited nuclear Fos-LI compared with AVP-LI neurons in the PVN and the SON. In situ hybridization histochemistry showed that ICV administration of AM2 (0.2, 1, and 2 nmol/rat) caused marked induction of the expression of the c- fos gene in the PVN and the SON. This induction was significantly reduced by pretreatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37) (3 nmol/rat) and the AM receptor antagonist AM-(22–52) (27 nmol/rat). These results suggest that centrally administered AM2 mainly activates OXT-secreting neurons in the PVN and the SON, at least in part through the CGRP and/or AM receptors with marked elevation of plasma OXT levels in conscious rats. c- fos ; fos; paraventricular nucleus; supraoptic nucleus; vasopressin Address for reprint requests and other correspondence: Y. Ueta, Dept. of Physiology, School of Medicine, Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan (e-mail: yoichi{at}med.uoeh-u.ac.jp )</description><subject>Adrenomedullin</subject><subject>Animals</subject><subject>Arginine Vasopressin - antagonists &amp; inhibitors</subject><subject>Arginine Vasopressin - blood</subject><subject>Arginine Vasopressin - metabolism</subject><subject>Calcitonin Gene-Related Peptide - pharmacology</subject><subject>Calcitonin Gene-Related Peptide Receptor Antagonists</subject><subject>Immunohistochemistry</subject><subject>In Situ Hybridization</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neuropeptides - pharmacology</subject><subject>Oxytocin - antagonists &amp; inhibitors</subject><subject>Oxytocin - blood</subject><subject>Oxytocin - metabolism</subject><subject>Paraventricular Hypothalamic Nucleus - cytology</subject><subject>Paraventricular Hypothalamic Nucleus - drug effects</subject><subject>Paraventricular Hypothalamic Nucleus - metabolism</subject><subject>Peptide Fragments - pharmacology</subject><subject>Proto-Oncogene Proteins c-fos - biosynthesis</subject><subject>Proto-Oncogene Proteins c-fos - genetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Supraoptic Nucleus - cytology</subject><subject>Supraoptic Nucleus - drug effects</subject><subject>Supraoptic Nucleus - metabolism</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkUGP1CAYhonRuOPqH_BgOHmyI9DSlqOZ7KrJJl7WM6HlY4YNhQpUtz9h_7WMM-uejCfg433efHlfhN5SsqWUs4_qbgavw5YQ0rAtI4Q_Q5vywSrKOX-ONoSKuqJ9Iy7Qq5Tuiq7jDXuJLigXvCW83qCHHfgclXMrVnqy3qYMEXR5RPBhAr04Zz1mWI3Z_lQZEj6sc8gH5dRkRxzu1xxG66sEY4Rs_R57WGLw6QMe1ZKOA3BwJDWenUqT-svgMgeHyyWqnF6jF0a5BG_O5yX6fn11u_tS3Xz7_HX36aYaG0JzBXpoREc16IYZ0rdG9IbpQUEz9JT33TgooYVRZKwHgLZujNC14V1JhxCj-_oSvT_5zjH8WCBlOdk0gnPKQ1iSbPu2FaLp_iukXS1YSb0I2Uk4xpBSBCPnaCcVV0mJPDYlz03JP03JY1MFend2X4YS8xNyrqYIxElwsPvDLxtBzoc12eDCfpXXpZZbuM-PzqwXksurjtdy1qaw1b_Zx2WemPo3wBq6zw</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Hashimoto, Hirofumi</creator><creator>Hyodo, Susumu</creator><creator>Kawasaki, Makoto</creator><creator>Mera, Takashi</creator><creator>Chen, Lei</creator><creator>Soya, Atsushi</creator><creator>Saito, Takeshi</creator><creator>Fujihara, Hiroaki</creator><creator>Higuchi, Takashi</creator><creator>Takei, Yoshio</creator><creator>Ueta, Yoichi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats</title><author>Hashimoto, Hirofumi ; Hyodo, Susumu ; Kawasaki, Makoto ; Mera, Takashi ; Chen, Lei ; Soya, Atsushi ; Saito, Takeshi ; Fujihara, Hiroaki ; Higuchi, Takashi ; Takei, Yoshio ; Ueta, Yoichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adrenomedullin</topic><topic>Animals</topic><topic>Arginine Vasopressin - antagonists &amp; inhibitors</topic><topic>Arginine Vasopressin - blood</topic><topic>Arginine Vasopressin - metabolism</topic><topic>Calcitonin Gene-Related Peptide - pharmacology</topic><topic>Calcitonin Gene-Related Peptide Receptor Antagonists</topic><topic>Immunohistochemistry</topic><topic>In Situ Hybridization</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neuropeptides - pharmacology</topic><topic>Oxytocin - antagonists &amp; inhibitors</topic><topic>Oxytocin - blood</topic><topic>Oxytocin - metabolism</topic><topic>Paraventricular Hypothalamic Nucleus - cytology</topic><topic>Paraventricular Hypothalamic Nucleus - drug effects</topic><topic>Paraventricular Hypothalamic Nucleus - metabolism</topic><topic>Peptide Fragments - pharmacology</topic><topic>Proto-Oncogene Proteins c-fos - biosynthesis</topic><topic>Proto-Oncogene Proteins c-fos - genetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Supraoptic Nucleus - cytology</topic><topic>Supraoptic Nucleus - drug effects</topic><topic>Supraoptic Nucleus - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashimoto, Hirofumi</creatorcontrib><creatorcontrib>Hyodo, Susumu</creatorcontrib><creatorcontrib>Kawasaki, Makoto</creatorcontrib><creatorcontrib>Mera, Takashi</creatorcontrib><creatorcontrib>Chen, Lei</creatorcontrib><creatorcontrib>Soya, Atsushi</creatorcontrib><creatorcontrib>Saito, Takeshi</creatorcontrib><creatorcontrib>Fujihara, Hiroaki</creatorcontrib><creatorcontrib>Higuchi, Takashi</creatorcontrib><creatorcontrib>Takei, Yoshio</creatorcontrib><creatorcontrib>Ueta, Yoichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashimoto, Hirofumi</au><au>Hyodo, Susumu</au><au>Kawasaki, Makoto</au><au>Mera, Takashi</au><au>Chen, Lei</au><au>Soya, Atsushi</au><au>Saito, Takeshi</au><au>Fujihara, Hiroaki</au><au>Higuchi, Takashi</au><au>Takei, Yoshio</au><au>Ueta, Yoichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>289</volume><issue>5</issue><spage>E753</spage><epage>E761</epage><pages>E753-E761</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>1 Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu; 2 Laboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, Tokyo; and 3 Department of Integrative Physiology, University of Fukui, Fukui, Japan Submitted 4 February 2005 ; accepted in final form 9 June 2005 We examined the effects of intracerebroventricular (ICV) administration of adrenomedullin 2 (AM2) on plasma oxytocin (OXT) and arginine vasopressin (AVP) levels in conscious rats. Plasma OXT levels were markedly increased 5 min after ICV administration of AM2 (1 nmol/rat) compared with vehicle and remained elevated in samples taken at 10, 15, 30, and 60 min. By contrast, plasma AVP levels were not significantly elevated in samples taken between 5 and 180 min after ICV administration of AM2 except at the 30-min time point. Fos-like immunoreactivity (Fos-LI) was observed in various brain areas, including the paraventricular (PVN) and the supraoptic nuclei (SON) after ICV administration of AM2 (2 nmol/rat) in conscious rats (measured at 90 min post-AM2 infusion). Dual immunostaining for OXT/Fos and AVP/Fos showed that OXT-LI neurons predominantly exhibited nuclear Fos-LI compared with AVP-LI neurons in the PVN and the SON. In situ hybridization histochemistry showed that ICV administration of AM2 (0.2, 1, and 2 nmol/rat) caused marked induction of the expression of the c- fos gene in the PVN and the SON. This induction was significantly reduced by pretreatment with both the calcitonin gene-related peptide (CGRP) antagonist CGRP-(8–37) (3 nmol/rat) and the AM receptor antagonist AM-(22–52) (27 nmol/rat). These results suggest that centrally administered AM2 mainly activates OXT-secreting neurons in the PVN and the SON, at least in part through the CGRP and/or AM receptors with marked elevation of plasma OXT levels in conscious rats. c- fos ; fos; paraventricular nucleus; supraoptic nucleus; vasopressin Address for reprint requests and other correspondence: Y. Ueta, Dept. of Physiology, School of Medicine, Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan (e-mail: yoichi{at}med.uoeh-u.ac.jp )</abstract><cop>United States</cop><pmid>15956053</pmid><doi>10.1152/ajpendo.00042.2005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2005-11, Vol.289 (5), p.E753-E761
issn 0193-1849
1522-1555
language eng
recordid cdi_proquest_miscellaneous_17392200
source American Physiological Society Free
subjects Adrenomedullin
Animals
Arginine Vasopressin - antagonists & inhibitors
Arginine Vasopressin - blood
Arginine Vasopressin - metabolism
Calcitonin Gene-Related Peptide - pharmacology
Calcitonin Gene-Related Peptide Receptor Antagonists
Immunohistochemistry
In Situ Hybridization
Injections, Intraventricular
Male
Neurons - drug effects
Neurons - metabolism
Neuropeptides - pharmacology
Oxytocin - antagonists & inhibitors
Oxytocin - blood
Oxytocin - metabolism
Paraventricular Hypothalamic Nucleus - cytology
Paraventricular Hypothalamic Nucleus - drug effects
Paraventricular Hypothalamic Nucleus - metabolism
Peptide Fragments - pharmacology
Proto-Oncogene Proteins c-fos - biosynthesis
Proto-Oncogene Proteins c-fos - genetics
Rats
Rats, Wistar
Supraoptic Nucleus - cytology
Supraoptic Nucleus - drug effects
Supraoptic Nucleus - metabolism
title Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A17%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Centrally%20administered%20adrenomedullin%202%20activates%20hypothalamic%20oxytocin-secreting%20neurons,%20causing%20elevated%20plasma%20oxytocin%20level%20in%20rats&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Hashimoto,%20Hirofumi&rft.date=2005-11-01&rft.volume=289&rft.issue=5&rft.spage=E753&rft.epage=E761&rft.pages=E753-E761&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00042.2005&rft_dat=%3Cproquest_cross%3E17392200%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c401t-edb4971ded42f086f98f2dbae4b81587cba9d9fa0c3bee634f9d3f5700500fd83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17392200&rft_id=info:pmid/15956053&rfr_iscdi=true